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Absence of Morphologic Correlation
between Chemical Toxicity and Chemical
Carcinogenesis
by James Huff
The experimental data set used to evaluate site-specific histopathologic correspondence
between the morphologic end points of toxicity and carcinogenicity comprises 130 chemical
carcinogenesis studies. Nearly 1500 sex-species-exposure-group experiments were evaluated
for a) evidence oftoxicity or/and carcinogenicity, b) dose-response relationships, c) site-specific
correlations oftoxicity and carcinogenicity, and d) correspondence with Salmonella mutagenic-
ity. The major conclusions are that chemicals evaluated for long-term toxicity and carcino-
genicity in experimental animals divide typically and consistently into three categories: a)
chemicals causing organ toxicity without cancer, b) chemicals causing site-specific cancer with
no associated toxicity, and c) chemicals causing both toxicity and cancer in the same organ.
Few chemicals overall (and none in this data set) fit the remaining group that cause neither
toxicity nor carcinogenicity under these protocol conditions. Mutagenicity exhibited no consis-
tent pattern with any ofthese groupings. Only 7 of53 "positive" chemicals had target organ tox-
icity at all sites of carcinogenicity. Just three chemicals showed carcinogenic effects at the
highest exposure concentrations without supporting evidence of tumors at the lower levels.
From these comparative morphological analyses, and for almost all cases, available data do not
support a correlation between chemically induced toxicity or regenerative phenomena and car-
cinogenicity. Consequently, until scientific knowledge about molecular mechanisms of chemi-
cal carcinogenesis becomes better understood and generally accepted, attempts to use toxicity
findings to modify risk assessment processes will be fraught with uncertainty and thus could
have a negative impact on public health.
Introduction
Most naturally occurring and synthetically made
chemicals are considered neither potentially carcino-
genic to humans (1-3) nor to animals (2,4-6), and the
proportion of chemicals eventually identified to cause
cancer in experimental animals or in humans is pre-
dicted to be relatively low (7-9). For those chemicals
identified as being causally associated with cancers in
humans, all have been shown to cause cancer in labora-
tory animals (10,11) with at least one site of cancer
being common to both mammalian subspecies (12-18).
This knowledge, together with patent similarities in
mechanisms ofcarcinogenesis across species, led to the
scientific and public health logic that chemicals shown
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clearly to be carcinogenic in animals (2,10-12, 15,16,
19-26) should be considered as likely to present cancer
risks to humans (1,3). So far, fewer than 200 agents or
exposure circumstances have been identified as being
causally or strongly implicated in human cancers. One
key public health factor too long ignored shows that of
the discrete chemicals associated with these human
diseases, nearly 30 were found to cause cancer in
experimental animals before being identified as car-
cinogenic to humans (12,27,28).
Chemical carcinogenesis experiments are conducted
largely to identify those chemicals, mixtures of chemi-
cals, or environmental and occupational exposures that
may potentially induce cancer in humans (4,5,15,29-31).
Results from these studies are the most reliable and
practical means to identify carcinogenic hazards in the
absence ofadequate and dependable human data (9,15,
29,32), and their value and use for protection ofpublic
health are without peer (16,19,33). In the last decade
and continuing into this one, as we accumulate more
knowledge about the molecular biology of cancer, sci-
entific debates resurface periodically over the value,J. HUFF
relevance, and use of various practical or mechanistic
assumptions or data in risk assessments of chemical
carcinogens (34-46).
One mechanistic issue centers on whether chemical-
induced toxicity per se (typically including adaptive
responses and cellular degeneration, death, and regen-
eration, thus signalling cellular proliferation) exerts
any significant influence on the chemical carcinogene-
sis processes. An empirical assessment of an extensive
series of long-term chemical carcinogenesis experi-
ments was made to ascertain whether there were any
direct and uniform causal associations between chemi-
cally induced cellular toxicity and carcinogenicity. This
issue is the central topic ofthis paper.
Experimental Data Sources
The core carcinogenicity database used for these
morphologic comparisons was originated in the late
1960s by the National Cancer Institute, and since 1978
has been continued by the National Toxicology
Program. The extensive files contain, among other sets
of information, a) gross and histopathology data from
long-term (typically 24-month) carcinogenesis studies
on more than 450 natural or synthetic chemicals, b)
nearly 1800 individual sex-species experiments, c)
6000 separate control and exposure groups, d) data and
tissues on 325,000 laboratory rodents, and e) 13 million
tissue sections that have been evaluated for toxicity
and carcinogenicity.
The experimental histopathology data used to evalu-
ate site-specific correspondence between toxicity and
carcinogenicity comes from a subset of 130 chemical
carcinogenesis studies. Nearly 1800 sex-species con-
trol and exposure group experiments were evaluated
for evidence of toxicity or/and carcinogenicity, dose-
response relationships, site-specific correlations oftox-
icity and carcinogenicity, and correspondence with
Salmonella mutagenicity.
Composite Results
Experimental details for the data summarized in this
paper are given in the NTP Technical Reports on indi-
vidual chemicals, from other compilations made from
this data set (4-6,17,32,47-49), and from previous
analyses ofthis mechanistic issue (43,50,51). These ref-
erences should be consulted for more details about the
experiments, names of chemicals evaluated, and
results.
Table 1 shows the numbers of experiments and the
summary findings on the percentages of experiments
with positive (35%), equivocal (11%), and no evidence
(54%) of carcinogenicity. By viewing the data in this
manner (as opposed to simply a "positive" or "nega-
tive" per chemical classification), one gets a better
appreciation for the actual rate or magnitude of posi-
tive responses. An even more valid approach involves
a qualitative grouping according to the number of
Table 1. Overall summary results from 485 sex-species
experiments on 130 chemical carcinogenesis
studies in rodents.
Chemicals evaluated 130
Individual sex and species experiments 485
Individual control and exposure groups 1560
Overallgroupings ofthe 485 sex-species experiments
Positive evidence ofcarcinogenicity 170 (35%)
Equivocal evidence ofcarcinogenicity 51 (11%)
No evidence ofcarcinogenicity 264 (54%)
sex-species positive responses and carcinogenic target
organs one finds in these chemical studies (43); for
example, allyl isothiocyanate induced a few benign
tumors ofthe urinary bladder in male rats and no car-
cinogenic response in female rats or in male and female
mice, whereas glycidol caused tumors at 16 sites
among the four sex-species experiments. Thus, one
should not group all carcinogens together for the pur-
poses of setting priorities for public health protection
or for attempting to belittle the value ofexperimental
data.
Table 2 divides the data on 99 chemicals from Hoel et
al. (50) into various groups for deciphering the issue
surrounding the "high dose only" paradigm of carcino-
genicity in rodents (36). For illustration, of the 127
"positive" responses, only 12 (or 6% of 198) of the
experiments showed chemically induced cancers at the
highest exposure level without similar related tumors
in the same organ at lower levels. Obviously, the
"high-dose-only carcinogens" theory does not reflect
the experimental findings. In most typical 2-year stud-
ies, those chemicals inducing positive carcinogenesis
responses do so at each ofthe exposure concentrations
(>90%); one does not know nor can one predict with
utmost confidence what the exact responses will be at
lower exposures, and the assumption must be that car-
cinogenic activity will be evidenced at lower doses as
well. In those cases in which additional experiments
were undertaken to obtain better knowledge about the
Table 2. Summary results from 370 sex-species experi-
ments on 99 chemical carcinogenesis studies in rodents.
Parameter Number (%)
Chemicals evaluated 99
Individual sex and species experiments 370
53 chemicals (198 experiments):
Positive at more than one dose 73 (37)
Positive at top exposure,
supported by lower dose increases 39 (20)
Positive at top exposure,
not supported by lower dose effects 12 (6)
Positive at only dose studied 3 (2)
Equivocal and no evidence 71 (36)
Total with positive evidence 127 (34)
Equivocal findings [overall] 35 (9)
No evidence ofresponse [overall] 208 (56)
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dose-response relationship, we invariably found con-
tinuation of carcinogenicity and/or preneoplasia at the
lower exposure concentrations. These findings are sim-
ilar to those reported by Tennant et al. (51), who evalu-
ated an additional 31 chemicals.
As a classical illustration ofthese natural phenomena
and to introduce the important issue of competing
risks, 1,3-butadiene was shown to be particularly car-
cinogenic at 625 and 1250 ppm when administered for 1
year (52). To extend the response curves, Melnick et al.
(53) designed a matrix ofexperiments including groups
exposed to only 6.25 ppm (as well as a series of
"start-stop" exposure groups). 1,3-Butadiene was car-
cinogenic even at 6.25 ppm, induced tumors at a site
(lung) different from higher exposures when animals
survived longer due to fewer lymphomas ("competing
risks"), and caused cancers with only 13 weeks ofexpo-
sure to 625 ppm. Benzene is another example of a par-
ticularly potent carcinogen (20), first shown by Maltoni
and Scarnato (54,55) and Maltoni et al. (56) to cause
cancers in laboratory animals at exposures of50 mg/kg
and above by the oral route and at concentrations of
200 ppm by the inhalation route. We substantiated the
responses at 50 mg/kg and extended this to 25 mg/kg
[or by conversion factors to 19 ppm by inhalation (57)].
Clearly, benzene (and 1,3-butadiene) would be carcino-
genic at exposures below those so far evaluated and
reported.
Other examples of repeated experiments are few,
but several can be mentioned, each of which is
carcinogenic at all exposures studied-dibromochloro-
propane (0.6 ppm lowest exposure level), dibro-
moethane (10 ppm) and 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD; 0.001 jg/kg). Other chemicals have
been evaluated and shown to be carcinogenic at very
low exposures, and there is no need to conduct repeat
studies-for examples, C.I. Acid Red 114 (70 ppm in
water), dimethylbenzidine (30 ppm in water), ethylene
oxide (50 ppm inhalation), furan (2 mg/kg oral), ochra-
toxin A (70 pg/kg oral), tetranitromethane (0.5 ppm
inhalation), and trichloropropane (3 mg/kg oral). Of
course, the important issue should not center on the
exposure concentration alone (4), but should also con-
sider the amounts, diversity, and multiplicity of expo-
sures humans receive typically and constantly. Clearly,
human exposures are predicted on the acute toxicity of
a chemical; that is, humans are exposed to considerably
more dichloromethane (methylene chloride), often up
to 4000 ppm in paint stripping, than to more toxic
chemicals such as formaldehyde (5-10 ppm). Thus,
potency of carcinogenic activity must be gauged using
other information as well. For example, for two chemi-
cals considered to be carcinogenic to humans, TCDD,
the most potent carcinogen yet discovered in animals
(58-60), would appear to be less hazardous to humans
(i.e., few people exposed at relatively low levels) than
analgesic mixtures containing phenacetin (i.e., many
people exposed occupationally and therapeutically at
relatively high levels).
Table 3. Summary results on toxicity and carcinogenicity
from 53 chemicals causing tumors in at least one sex of
one species.
Result Number (%)
Target organ effects
Site-specific carcinogenic effects 207
No toxic lesions or hyperplasia 91 (44)
Hyperplasia without toxicity 52 (25)
Toxic lesion with hyperplasia 34 (16)
Toxic lesion without hyperplasia 30 (14)
Liver lesions
Rats Mice
Carcinoma 21 42
Without toxicity 13 22 (56)
With toxicity 8 20 (44)
Table 3 separates the 207 carcinogenic responses
induced by these 53 chemicals into those with and
without toxicity and hyperplasia. Again, one must
evaluate the spectrum of responses observed before
deciding whether an empirical association between
various end points (e.g., toxicity and carcinogenicity)
reflects a cause-and-effect relationship-especially for
a single chemical regarding mechanism. For the actual
data, the majority of site-specific responses (44%)
showed no toxicity or hyperplasia, and for only 14% (30
sites) of the carcinogenic effects were there toxic
lesions in the organ sites exhibiting carcinogenic
effects.
Liver Carcinogenesis
For chemically induced carcinogenic responses in the
liver, there seems to be an increasing tendency to posit
that toxicity is indeed associated with carcinogenesis
(and in particular for "nongenotoxic chemical carcino-
gens"). Because ofthis and because chemically induced
liver tumors in rodents represent the most frequent
target site (61, 62), these were tabulated separately
(Table 3). The above contention has little support, as
there appears to be no consistent pattern of toxicity
with or without neoplasia. The recorded observations
divide almost evenly regarding chemicals causing can-
cer with or without toxicity, orienting toward those
chemicals inducing cancer without toxicity (56% versus
44%). This nearly equal distribution was consistent for
both species. As with other organs, whether more sub-
tle lesions were occurring than could be observed
using light microscopy remains to be determined.
Conversely, for those livers exhibiting overt patterns
oftoxicity, there was little or no chance ofoverlooking
a neoplasm (63).
1,4-Dichlorobenzene, unleaded gasoline, and furan
are interesting examples for which cell proliferation
studies were conducted after the knowledge that these
"nongenotoxic" chemical were carcinogenic to labora-
tory animals. Using 1,4-dichlorobenzene for illustra-
tion, increases in hepatocyte proliferation (and in liver
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weights) were observed in both sexes of mice and in
female (males not studied) rats (64); yet hepatocarcino-
genic responses were restricted to mice. The major
increases in S-phase labeling were seen only at week 1
of the 13-week studies and diminished substantially
thereafter. The labeling index increase at week 1 was
greatest in female rats (35% of heptocytes in S-phase
at 600 mg/kg dose versus 1.2% in controls) and lowest
in female mice (7.5% versus 2.9% in controls; males,
7.3% versus 0.1% in controls), yet tumors of the liver
were induced only in mice (females from 15/50 in con-
trols to 36/50 exposed; males from 17/50 to 40/50) com-
pared to none in rats (only one carcinoma in a control
male rat; none in exposed male or female rats). Clearly,
one must question the a priori notion that toxicity and
cellular proliferation (for 1 week) were intimately and
ultimately involved in the mechanism of liver carcino-
genesis (65) for 1,4-dichlorobenzene. Similarly, unlead-
ed gasoline induced liver tumors in female mice,
whereas increased cellular proliferation was observed
in both sexes of mice (66). Both of these studies sug-
gest additional factors are involved in the hepatocar-
cinogenicity ofchemicals.
Furan-induced carcinogenicity of the liver in rats
and mice illustrates another potentially premature
mechanistic interpretation. In a 6-week study using
only the highest exposures from the 2-year NTP car-
cinogenesis studies, the labeling index in hepatocytes
was elevated at week 1 in rats (3.2% in males versus
0.08% in controls, 11.7% in females versus 0.8% in con-
trols) and in male mice (25.1% versus 0.4% in controls;
female mice not studied). For mice, the rate oflabeling
at 6 weeks was only about 3%, down from roughly 13%
at week 3, and 25% at week 1 (67); thus, one could
assume physiologic adaption to this chemical effect.
The major carcinogenic response from furan was
cholangiocarcinomas of the liver, but bile duct cell
proliferation was not measured. The proliferative
response was greater in female than in male rats, while
the carcinogenic response was much greater in males.
Table 4 divides the chemicals by various toxic and
preneoplastic end points (as compared to Table 3 for
individual target sites). For 29 of 53 chemicals (55%)
showing a positive carcinogenic response in at least
one organ of one sex of one species, 11 ofthese induced
toxic lesions in all cancer sites. Four of these 11
induced toxicity not considered likely to influence the
particular tumor type observed; thus for 7 of the 53
chemicals (13%), toxic lesions occurred in all target
sites and at each of the exposure levels. Table 5 lists
the 11 chemicals with the target organs and the muta-
genicity results from the Salmonella assay. Three of
these chemicals caused tumors in all four sex-species
experiments, and in each case the carcinogenic
responses were single target sites: ethyl acrylate
caused benign and malignant neoplasia of the fore-
stomach; polybrominated biphenyls induced cholangio-
carcinomas of the liver; propylene oxide produced
hemangiosarcomas of the nasal cavity. Two chemicals
Table 4. Numbers ofchemicals causing or not inducing
neoplastic lesions with or without toxic or/and preneo-
plastic lesions from 99 2-year studies.
Description Number
Chemicals causingneoplasia 53
No toxic lesion or hyperplasiaa 13
Preneoplastic lesionsb 11
Toxic lesions in at least one cancer target sitec 29
One or more experiments without a
toxic lesion at cancer site 18
Toxic lesions in all cancer sites 11
Toxic lesions at all cancer sites
considered not associated with
cancereffects 4
Toxic lesions observed in all
cancer target sites 7
Chemicals not causingneoplasia 46
a Difficult to evaluate all organs and systems for toxic lesions or
hyperplasia in experiments without neoplastic effects.
bSpecific organs tabulated for non-neoplastic lesions were liver,
forestomach, kidney, urinary bladder, and nasal cavity.
c Results show patterns of toxicity similar to those observed in
organs exhibiting carcinogenesis.
Table 5. Neoplasms induced for 11 chemicals with toxic
lesions in all cancer sites and for all exposure levels.
Rat Mouse
Chemical S M F M F
l.Chlorodibromomethanea,b- None None None Liver
2. C.I. Disperse Blue lac + UB UB None None
3. 1,4-Dichlorobenzene - K None Liver Liver
4. Ethyl acrylate - FS FS FS FS
5. Isophorone - K None None None
6. Melamine - UB None None None
7. Pentachloroethane - None None Liver Liver
8. PBB (FiremasterFF-l)ad - Liver Liver Liver Liver
9. Propylene oxide 1,a,e + NC NC NC NC
10. 1,1,1,2-Tetrachloroethane - None None Liver Liver
11. 2,6-Xylidine ± NC NC
Abbreviations: UB, urinary bladder; K, kidney; FS, forestomach;
NC, nasal cavity; -, not done.
aTumors not considered related to toxicity, or increase in uncom-
mon tumors.
bCytoplasmic vacuolization.
cSquamous, transitional, and mesencymal cell tumors.
dTypical liver cell toxicity, with tumors ofthe bile duct (cholangio-
carcinomas).
eInflammation, vascularneoplasia (hemangiosarcomas).
caused tumors in one site of one sex of one species:
isophorone (kidney) and melamine (tumors of the uri-
nary bladder). Only one chemical (1,4-dichlorobenzene)
induced tumors in two organs, kidney and liver.
Table 6 summarizes results from the 90-day toxicity
experiments, used mainly to determine target organs
and toxicity dose-response relationships, as well as to
aid in the selection of exposure levels for the longer-
term carcinogenesis studies. In most if not all cases,
the concentrations used in the 13-week studies were
higher than those eventually selected for the 2-year
studies (31,32), the thesis being that if exposures are
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Table 6. Summary results on toxicity observed from 51
prechronic (13-week, 90-day) studies compared to positive
carcinogenicity from 2-year studies.
No lesions oftoxicity or preneoplasia
Toxic lesions only in organs not
resulting in cancer (nontargets)
Toxic lesions in some 2-yr tumor sites
Toxic lesions in all eventual cancer target sites
Salmonella
1. C.I. Disperse Blue 1 (anthraquinone)
2. C.I. Solvent Yellow 14 (monoazo)ab
3. D & C Red No. 9 (azo pigment)ac
4. 1,4-Dichlorobenzene
5. Digycidol resorcinol ethera!
6. Ethyl acrylate
7. Melamine
8. Trichloroethylenea,I
9. 4-Vinylcyclohexeneah
13
16
13
9
aChemicals causing cancer but not showing toxic lesions in those
same organs in 2-year experiments.
bHyperplasia only.
dHyperplasia with/without toxicity.
(INo toxicity or hyperplasia.
chosen below those that showed overt (histologically
detectable) toxicity in short-term experiments, it will
prevent or reduce confounding interpretative factors
such as the development of life-threatening lesions or
excessive adverse influences on normal health and
well-being (e.g., lowered body weight gain and reduced
survival compared to controls) from factors other than
carcinogenesis. Nine chemicals showed toxic lesions in
each of the eventual cancer target sites. Five of these
nine chemicals induced cancer in organs not showing
any concomitant toxicity, probably because the lesions
were seen at higher ("toxic") doses in the 90-day
experiments or because adaptation occurred during
the long-term exposure regimen.
As an illustration, 13-week exposures to trichloro-
ethylene were associated (only retrospectively) with
minimal or mild cytomegaly and karyomegaly of the
renal tubular epithelial cells of the inner cortex in 8/9
male rats receiving 2000 mg/kg and with equivocal or
minimal lesions in 5/10 female rats given 1000 mg/kg.
The renal effects were so minimal that they were diag-
nosed only during a reevaluation after definite renal
toxicity was seen in the 2-year studies. In the latter
experiments, "toxic nephrosis" (called "cytomegaly")
was present in 98% of males and in 100% of females
(severity grades ranging from 1.9 to 3.1), but was not
found in controls. Despite this consistent toxicity, only
three high-dose males had adenocarcinoma ofthe tubu-
lar cells, two low-dose males had tubular cell adeno-
mas, and one high-dose female rat had a tubular cell
adenocarcinoma.
Nonetheless, these tumors are quite rare in control
animals, and the detection of even one such tumor in
female rats may be cause for further investigation
(including step-sectioning remaining portions of kid-
ney). Control male rats typically show moderate-to-
marked nephropathy (grades 2.5-3.5) at 2 years, and
kidney tumors in controls (80% benign in males and
100% benign in females) occur in only 10/1000 (0.5
tumors/group of 50) male Fischer rats and in 1 or
2/1000 (0.15 tumors/group of 50) female rats. Thus,
even a low incidence in this strain must be evaluated
closely for possible chemical causation.
To ascertain the possible effect of aging on tumor
incidences, a histopathologic comparison was made (68)
of 2320 young (110-116 weeks of age for 2-year stud-
ies) and 529 old (140-146 weeks) F344 control male
rats; no differences were reported for tubular cell
tumors of the kidney: 0.3% (3/1000) versus 0.6%
(6/1000). Given that all animals with tumors ofthe kid-
ney invariably exhibit toxicity ("spontaneous"
nephropathy) as well, and typically there are larger
numbers of animals (control and exposed) with toxic
lesions (trichloroethylene, for example, mentioned
above) and/or no cancer ofthe kidney (69,70), empirical
correlations are virtually impossible. If a chemical
induces a unique and easily discernable toxic lesion
[e.g., tris(2,3-dibromopropyl)phosphate (71)] or a lesion
of a greater severity than that seen in aged animals
and only those animals get cancer, then a more logical
correlation can be made. Nonetheless, more mechanis-
tic-oriented studies are then needed to ascertain corre-
lation causality.
On examining the non-neoplastic and neoplastic data
reported in the NTP Technical Report Series for those
approximately 40 chemicals causing tumors of the kid-
ney (62,69), some might conclude that an empirical cor-
relation exists between toxicity (e.g., nephropathy)
and carcinogenicity (tumors) because all animals with
tumors exhibit toxicity. The interpretative difficulty
for the kidney has been mentioned above in that if all
animals have nephropathy, there can be no or little
chance for statistical correlation. In some but not all
cases, one can differentiate between age-related
nephropathy and chemical nephropathy (e.g., TRIS);
however, even in these situations the differences in
severity rarely exceed a half grade point, and some
believe that at least a full grade point difference is
needed in this subjective diagnostic criteria before one
could conclude that a significant biological difference
exists.
Regarding the effects of trichloroethylene in B6C3F,
mice, 13 weeks of exposure resulted in centrilobular
necrosis of the liver in 6/10 males and in 1/10 females
given 6000 mg/kg; <3000 mg/kg did not induce this
lesion. As in rats, reevaluation of kidney sections
revealed cytomegaly and karyomegaly in both sexes of
most animals in the 3000 and 6000 mg/kg groups and
none in the 1500 mg/kg or lower exposure groups. In
the single exposure level of 1000 mg/kg selected and
used in the 2-year studies, toxic nephrosis ("cyto-
megaly") was diagnosed in 90% of males (1.5 severity)
and in 98% of females (1.8 severity; none in controls).
One control male (adenoma) and one exposed male
(adenocarcinoma) had tubular cell tumors. In the liver,
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adenomas, carcinomas, and metastases were increased
in exposed animals; interestingly there was no evi-
dence whatsoever of non-neoplastic (toxic) lesions of
the liver. These responses (i.e., tumors with no toxici-
ty) have been mimicked in methylene chloride inhala-
tion experiments in which lung and liver cancers were
induced with no observed toxicity or increase in cell
proliferation. Thus, toxicity findings from higher expo-
sures in short-term experiments or observed toxicity
in long-term experiments (e.g., kidney) cannot be used
mechanistically to either predict eventual carcino-
genicity or to advocate toxicity and resultant sequalae
as a mechanism oftumor development.
Discussion
The renewed attention given to the role of chemical-
ly induced and sustained cell proliferation in carcino-
genesis (36-39,72) represents a renewed attempt to
define this role, in spite of the fact that few studies
have been accomplished in regard to this potential
relationship. Statements are being made and debated
about mechanisms of chemical carcinogenesis as if
these statements were based on factual data, duly
deliberated, and consensus reached in the historical
scientific paradigm (73). Obviously, cell division and
replication are essential to the carcinogenesis process
(74); if these proliferative processes were not occur-
ring, regardless ofany carcinogenic exposures, then no
cancers would develop. The question is, does cell prolif-
eration, enhanced by whatever means, cause or influ-
ence the carcinogenesis process? I believe that, in
addition to being necessary for tumor development,
"induced" cell proliferation may indeed influence the
carcinogenic activity ofchemicals either by a) reducing
the latency time for tumor development or/and by b)
increasing the numbers and perhaps multiplicity of
tumors harvested. I do not believe, and there are no
data to support, the notion that simply increasing cell
turnover leads to or causes cancer. A plethora of
experimental data do exist to support the conclusion
that toxicity and resultant compensatory cellular
replacement do not often associate with cancer. The
extensive facts to the contrary in this paper testify, as
do other papers in these proceedings [e.g., Ward et al.
(75)], to this conclusion.
As two examples, one regarding renal carcinogenesis
and mechanism, Short (76) states that "correlative
studies with a number of other renal carcinogens and
noncarcinogens are warranted before general conclu-
sions can be made", and that "underlying mechanisms
of chemically induced cell proliferation must be under-
stood before cause-and-effect relationships between
renal cell proliferation and enhancement of the stages
of renal cancer are made." Similarly, in the other
example, relating to nasal cancer, Monticello et al. (77)
stress "that cell proliferation in response to cell death
is not the sole determinant in nasal carcinogenesis,
since other inhaled irritant gases, such as dimethy-
lamine, induce severe nasal cytotoxicity, inflammation,
and squamous metaplasia, yet do not induce nasal
tumors following chronic exposure. Additional work is
needed to delineate the correlation between nasal toxic
responses, epithelia proliferation, and the carcinogenic
process."
Under the conditions of this experimental research,
toxic and carcinogenic lesions were diagnosed using
typical light microscopic techniques together with
standard histologic and morphological criteria. Lesions
of toxicity were considered frequently to be identical
to those often associated with chronic or sustained
cellular proliferation. Examples include epithelial
hyperplasia in the nasal cavity, basophilic tubular
nephropathy, and necrosis/regeneration in the liver.
Interestingly, for chemicals causing cancer in just one
sex ofone species, we typically observe identical toxic-
ity in the other sex and in many cases in both sexes of
the second species. As one example, talc by inhalation
exposure induced an enormous number and variety of
proliferative lesions of the lung in both sexes of rats
and mice; yet this agent caused cancer of the lung in
only female rats. Why? Lung tumors are not gender or
species specific (62), nor are they typically considered
hormonally mediated. Perhaps experiments of longer
duration might unlock this dichotomy (as seen for
asbestos or cadmium-associated cancers, in that virtual
life-span exposure studies were necessary before
agent-induced tumors were observed).
The major conclusions reached from these investiga-
tions are that chemicals evaluated for long-term toxici-
ty and carcinogenicity in experimental animals divide
typically and consistently into three categories (43):
chemicals causing a) organ toxicity without cancer, b)
site-specific cancer with no associated toxicity, and c)
both toxicity and cancer in the same organ (see Table
7). A fourth category could be formed to include those
Table 7. Major conclusions based on the histopathological
evaluations ofchemically induced toxicity and
carcinogenicity from 99 long-term exposure studies
oflaboratory rodents.
1.Only 7 of53 chemicals causing tumors in at least one organ in one
sex ofone species had target organ toxicity at all sites ofcarcinogenic-
ity.
2.Only 3 chemicals showed carcinogenic effects at the highest expo-
sure concentrations, with no supporting evidence oftumors at the
lower levels.
3. Number ofchemical carcinogens with some possible "indirect (or
secondary) mechanism" (toxicity) is small.
4.Available data evaluated do not support a uniform correlation
between chemically induced toxicity and carcinogenicity.
5.Chemicals evaluated forlong-term toxicity and carcinogenicity in
experimental animals divide into three rank-order categories:
a. Chemicals causing organ toxicity without cancer
b. Chemicals causing site-specific cancer with no associated toxicity
c. Chemicals causing both toxicity and cancerin the same organ.
6.To differentiate chemicals into mechanisms ofcarcinogenesis (e.g.,
primary and secondary) for risk assessment purposes is premature.
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chemicals not causing any toxicity or carcinogenicity;
given that these are, in fact, toxicology experiments,
few chemicals fit this group (e.g., resorcinol).
For chemicals in the first group (5a in Table 7), there
can be no or little doubt that cell degeneration, cell
death, and cell regeneration (and hence cell replication,
although DNA synthesis was not measured) were
actively taking place in affected organs, yet no carcino-
genesis was observed. One can assume with reasonable
but not complete certainty that the obverse existed for
chemicals in group 5b in Table 7: no or only little or
subtle cellular replication was taking place in the even-
tually affected tissues before the carcinogenesis
process. Whether these chemicals may have preferen-
tially exerted influence on the cancerous foci remains
to be deciphered, but the evidence seems to indicate
this would be unlikely. Even for chemicals in group 5c
of Table 7, one would be mistaken to assume that the
observed toxicity was indeed the origin ofthe carcino-
genesis process, a mistake made often when one unwit-
tingly correlates short-term cellular proliferation find-
ings with eventual tumor development. Most would
agree, however, that induced cellular proliferation may
influence the interval to tumor occurrence as well as
the yield of tumors (78). No data exist to indicate that
a noncarcinogenic chemical can be made to be carcino-
genic simply by enhancing cellular proliferation ofnor-
mal tissue. Likewise, predicting whether a chemical
will be carcinogenic using short-term data on induced
cell proliferation will not likely be possible.
Too many variables and too many exceptions exist to
formulate some universal algorithm or biological con-
tinuum. In fact, to better define the role ofcell prolifer-
ation on the carcinogenesis process, more and better
designed cell turnover studies are needed that mimic
the experimental protocols used to determine the pres-
ence or absence of carcinogenesis in the first place.
Few studies of this type have actually been designed
or accomplished (79,80). Further, de novo long-term
chemical carcinogenesis studies should incorporate
(perhaps selectively) cell proliferation data collection
in the experimental design. A misguided criticism of
this generic experimental enhancement is the admoni-
tion that one does not know in advance which tissues
(ifany) will develop cancer; this actually does not mat-
ter because one will gain immeasurable information
regardless of whether a particular chemical turns out
to be carcinogenic or not or ifit causes cancer in anoth-
er organ. One needs only to direct efforts toward those
tissues and organs where responses are most likely to
be expected, using historical findings (62).
Until a considerably larger data set is established,
the role ofchemically enhanced cell proliferation in the
carcinogenic performance of a chemical can only be
speculated. And for now and into the immediate
future, one would be premature and probably incorrect
to make public health decisions on the basis of skimpy
scientific data regarding the influence of cell prolifera-
tion per se on the carcinogenesis process.
For thoughtful comments on this paper I thank Kamal Abdo, J.
Carl Barrett, and Ron Melnick. Donna Mayer helped with reference
citations.
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